IP Library Granted Patent US 12,467,039
Granted Patent B2
US 12,467,039 · App. 17/608,437 · Granted Nov 11, 2025

Kaurenoic acid 13-hydroxylase (KAH) variants and uses thereof

Inventors: Andrew P. Klein (Emeryville, CA); Sean Lund (Emeryville, CA); Gale Wichmann (Emeryville, CA); Irina Koryakina (Emeryville, CA); Kyle Hogan (Emeryville, CA); Svetlana Borisova (Emeryville, CA)
Assignee: Amyris, Inc.
C12N9/0073C12P19/56
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,467,039
App. No.
17/608,437
Granted
Nov 11, 2025
Kind
B2
Abstract

Provided herein are genetically modified host cells, compositions, and methods for improved production of steviol glycosides. The host cells are genetically modified to contain a heterologous nucleic acid that expresses novel and optimized variants of Ro.KAH. The host cell further contains one or more heterologous nucleotide sequence encoding further enzymes of a pathway capable of producing one or more steviol glycosides in the host cell. The host cells, compositions, and methods described herein provide an efficient route for the heterologous production of steviol glycosides including rebaudioside A, rebaudioside D, and rebaudioside M.

Claims (21)

1 . A kaurenoic acid hydroxylase variant comprising the amino acid sequence of SEQ ID NO:1, further comprising one or more amino acid substitutions selected from the group consisting of: W8G, L11V, W29A, W29C, W29T, W29V, V30F, N49A, N49R, F53R, L54G, Y55G, Y55P, Y55S, G56D, G56N, G56S, D57G, M58G, M58P, E60G, E60R, N61P, S62R, L64D, L64G, L64N, L65G, L65S, A68G, A68I, A68P, K69G, K69P, S70P, P72C, P72D, P72G, P72T, M73G, M73H, Q84C, Q84L, F88D, F88R, F88S, F88V, D102Y, I104A, I104D, 1104H, I104N, I104R, K119S, K119V, K119Y, T123D, I129R, 1132G, S133G, S133R, N160D, N160T, P161C, P161D, T162A, T162G, H164G, S165D, S165P, K167G, K167H, K167S, M171F, W202A, W202C, W202Q, W202V, L205I, E206D, N207F, A210G, T216A, T216G, A217L, A217V, T220E, T220R, K224C, K224I, K224V, F229Y, E230C, E230G, L232M, L232Y, R233C, R233T, A236R, I237C, Y238C, T240D, A242D, A242G, Q244D, Q244G, S245G, F246G, F246S, M258G, K267D, I284G, K291C, K291S, D292P, D293C, A297F, A297V, A297Y, L303D, K314P, C327I, F332L, Q335V, S339A, S339G, V340A, V340S, V343G, T378D, H379G, A396F, T403V, S452D, R458D, S460I, G466D, G466F, G466S, N475D, N475G, L485F, H491P, A503C, S505R, Y506V, R507A, R507E, R507G, I508L, T509V, Q513G, and Q513R.

2 . The variant of claim 1 , wherein the one or more amino acid substitutions are F332L/S452D.

3 . The variant of claim 1 , wherein the amino acids of an N-terminal signal sequence in SEQ ID NO:1 are replaced with the amino acids of an N-terminal signal sequence of a heterologous plant p450 polypeptide.

4 . The variant of claim 1 , wherein amino acids 1-25 of SEQ ID NO:1 are replaced with the amino acid sequence of SEQ ID NO:22.

5 . A nucleic acid encoding the variant polypeptide of claim 1 .

6 . A host cell comprising the polypeptide of claim 1 .

7 . The host cell of claim 6 , wherein the host cell is capable of producing one or more steviol glycosides.

8 . The host cell of claim 7 , wherein the one or more steviol glycosides are selected from RebA, RebB, RebD, RebE, and RebM.

9 . The host cell of claim 6 , further comprising one or more nucleic acids encoding one or more enzymes of a pathway for making a steviol glycoside, optionally wherein the host cell further comprises a nucleic acid encoding a geranylgeranyl diphosphate synthase, a nucleic acid encoding a geranylgeranyl diphosphate synthase, a nucleic acid encoding a copalyl diphosphate synthase, a nucleic acid encoding an ent-kaurene synthase, a nucleic acid encoding a kaurene oxidase, a nucleic acid encoding a cytochrome P450 reductase, and/or a nucleic acid encoding one or more uridine 5′-diphosphate-dependent glycosyltransferases.

10 . The host cell of claim 6 , wherein the cell is selected from a bacterial cell, a yeast cell, an algal cell, an insect cell, and a plant cell.

11 . The host cell of claim 10 , wherein the cell is a yeast cell.

12 . A method for producing one or more steviol glycosides comprising:

culturing a population of host cells of claim 6 in a medium with a carbon source under conditions suitable for making one or more steviol glycosides to yield a culture broth; and

recovering the one or more steviol glycosides from the culture broth.

13 . The method of claim 12 , wherein the one or more steviol glycosides is RebM.

14 . A fermentation composition comprising:

a host cell comprising a nucleic acid encoding a kaurenoic acid hydroxylase of claim 6 ; and

one or more steviol glycosides produced by the host cell.

15 . A host cell comprising a kaurenoic acid hydroxylase polypeptide comprising an amino acid sequence at least 90% identical to the amino acid sequence of SEQ ID NO: 1.

16 . The host cell of claim 15 , wherein the amino acid sequence of the kaurenoic acid hydroxylase polypeptide comprises the amino sequence selected from SEQ ID NO: 1, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 20, and SEQ ID NO: 21.

17 . The host cell of claim 11 , wherein the yeast cell is a Saccharomyces cerevisiae.

Assignments (6)
SECURITY INTEREST Recorded Jan 9, 2026
From: AMYRIS, INC.
To: EUAGORE, LLC
Reel/Frame 073419/0255 →
SECURITY INTEREST Recorded May 24, 2024
From: AMYRIS, INC.
To: EUAGORE, LLC
Reel/Frame 067528/0467 →
SECURITY INTEREST Recorded Aug 17, 2023
From: AMYRIS, INC.; AMYRIS CLEAN BEAUTY, INC.; AMYRIS FUELS, LLC; AB TECHNOLOGIES LLC; APRINNOVA, LLC; AMYRIS-OLINKA, LLC; ONDA BEAUTY INC.; UPLAND 1 LLC; AMYRIS ECO-FAB LLC; CLEAN BEAUTY 4U HOLDINGS, LLC; AMYRIS CLEAN BEAUTY LATAM LTDA; INTERFACES INDUSTRIA E COMERCIA DE COSMETICOS LTDA; AMYRIS BIOTECHNOLOGIA DO BRASIL LTDA; AMYRIS EUROPE TRADING B.V. (NETHERLANDS); AMYRIS BIO PRODCUTS PORTUGAL, UNIPESSOAL, LDA; BEAUTY LABS INTERNATIONAL LIMITED; AMYRIS UK TRADING LIMITED
To: EUAGORE, LLC
Reel/Frame 064619/0778 →
SECURITY INTEREST Recorded Aug 3, 2023
From: AMYRIS CLEAN BEAUTY, INC.; AMYRIS FUELS, LLC; AB TECHNOLOGIES LLC; AMYRIS, INC.
To: MUIRISC, LLC
Reel/Frame 064492/0518 →
SECURITY INTEREST Recorded Oct 18, 2022
From: AMYRIS, INC.
To: FORIS VENTURES, LLC
Reel/Frame 061703/0499 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2022
From: KLEIN, ANDREW P.; LUND, SEAN; WICHMANN, GALE; KORYAKINA, IRINA; HOGAN, KYLE; BORISOVA, SVETLANA
To: AMYRIS, INC.
Reel/Frame 058812/0457 →
Continuity (2)
Provisional Application 62842810 · May 3, 2019
Related Publication 20220282228A1 · Sep 8, 2022
References Cited (33)
US 10612064B2 · Robertson · 2020 [cited by examiner]
US 20170240942A1 · Lunde Robertson et al. · 2017 [cited by applicant]
US 20170369922A1 · Olsson et al. · 2017 [cited by applicant]
US 20180148750A1 · Anderson et al. · 2018 [cited by applicant]
US 20190078105A1 · Van Leeuwen et al. · 2019 [cited by applicant]
CN 107109358A · 2017 [cited by applicant]
CN 108396044A · 2018 [cited by applicant]
EP 3215629A4 · 2018 [cited by applicant]
JP 2017528134A · 2017 [cited by applicant]
WO WO2014122328A1 · 2014 [cited by applicant]
WO WO2015139599A1 · 2015 [cited by applicant]
WO WO2016038095A2 · 2016 [cited by applicant]
WO WO2017098017A1 · 2017 [cited by applicant]
WO WO2018031955A2 · 2018 [cited by applicant]
WO WO2018211032A1 · 2018 [cited by applicant]
WO WO2020081468A1 · 2020 [cited by applicant]
von Heijne, G. The Signal Peptide. J. Membrane Biol. 115, 195-201 (1990) (Year: 1990). [cited by examiner]
Jennings JC, Coolbaugh RC, Nakata DA, West CA. Characterization and Solubilization of Kaurenoic Acid Hydroxylase from Gibberella fujikuroi. Plant Physiol. Mar. 1993; 101(3):925-930. doi: 10.1104/pp.101.3.925. PMID: 1223… [cited by examiner]
Gangl D, Zedler JA, Włodarczyk A, Jensen PE, Purton S, Robinson C. Expression and membrane-targeting of an active plant cytochrome P450 in the chloroplast of the green alga Chlamydomonas reinhardtii. Phytochemistry. Feb… [cited by examiner]
Raymond et al., “The Rosa genome provides new insights into the domestication of modern roses,” Nat Genet. 50(6):772-7 (2018). [cited by applicant]
“Cytochrome P450 72A15-like isoform X1 [Rosa chinensis],” NCBI Protein Database Accession No. XP_024159575.1, accessed Mar. 19, 2018 (2 pages). [cited by applicant]
“Predicted: cytochrome P450 CYP72A219-like isoform X2 [Prunus mume],” NCBI Protein Database Accession No. XP_008226214.1, accessed May 11, 2016 (2 pages). [cited by applicant]
Kim et al., “Hydroxylation of ent-kaurenoic acid to steviol in Stevia rebaudiana Bertoni—purification and partial characterization of the enzyme,” Arch Biochem Biophys. 332(2):223-230 (Aug. 1996). [cited by applicant]
Extended European Search Report for European Patent Application No. 20802800, dated May 12, 2023 (15 pages). [cited by applicant]
Broun et al., “Catalytic plasticity of fatty acid modification enzymes underlying chemical diversity of plant lipids,” Science 282(5392):1315-7 (1998) (4 pages). [cited by applicant]
Whisstock et al., “Prediction of protein function from protein sequence and structure,” Q Rev Biophys. 36(3):307-40 (2003). [cited by applicant]
Seffernick et al., “Melamine deaminase and atrazine chlorohydrolase: 98 percent identical but functionally different,” J Bacteriol. 183(8):2405-10 (2001). [cited by applicant]
Witkowski et al., “Conversion of a beta-ketoacyl synthase to a malonyl decarboxylase by replacement of the active-site cysteine with glutamine,” Biochemistry. 38(36):11643-50 (Sep. 1999). [cited by applicant]
Novikova et al., “From structure and function of steroid enzymes to new technologies of gene engineering,” Adv Biol Chem. 49:159-210 (2009). [cited by applicant]
Office Action and Search Report for Chinese Patent Application No. 202080040694.5, dated Sep. 16, 2023 (18 pages). [cited by applicant]
Office Action for Japanese Patent Application No. 2021-564945, dated May 28, 2024 (7 pages). [cited by applicant]
Substantive Examination Adverse Report for Malaysian Patent Application No. PI2021006442, dated Sep. 24, 2024 (4 pages). [cited by applicant]
Written Opinion and Search Report for Singaporean Patent Application No. 11202111698S, dated Nov. 8, 2023 (10 pages). [cited by applicant]